Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925526.RAFkIlJZ4V5Q5K_3mOw7UmZEMS82WzcPZUsOFYDsqesMo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925526.RAFkIlJZ4V5Q5K_3mOw7UmZEMS82WzcPZUsOFYDsqesMo130_assertion type Assertion NP925526.RAFkIlJZ4V5Q5K_3mOw7UmZEMS82WzcPZUsOFYDsqesMo130_head.
- NP925526.RAFkIlJZ4V5Q5K_3mOw7UmZEMS82WzcPZUsOFYDsqesMo130_assertion description "[The Src kinase inhibitor dasatinib killed transformed BaF3 cells and other established murine leukemia cell lines expressing chimeric FGFR1 kinases, significantly extending the survival of mice with SCLL syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925526.RAFkIlJZ4V5Q5K_3mOw7UmZEMS82WzcPZUsOFYDsqesMo130_provenance.
- NP925526.RAFkIlJZ4V5Q5K_3mOw7UmZEMS82WzcPZUsOFYDsqesMo130_assertion evidence source_evidence_literature NP925526.RAFkIlJZ4V5Q5K_3mOw7UmZEMS82WzcPZUsOFYDsqesMo130_provenance.
- NP925526.RAFkIlJZ4V5Q5K_3mOw7UmZEMS82WzcPZUsOFYDsqesMo130_assertion SIO_000772 21937681 NP925526.RAFkIlJZ4V5Q5K_3mOw7UmZEMS82WzcPZUsOFYDsqesMo130_provenance.
- NP925526.RAFkIlJZ4V5Q5K_3mOw7UmZEMS82WzcPZUsOFYDsqesMo130_assertion wasDerivedFrom befree-2016 NP925526.RAFkIlJZ4V5Q5K_3mOw7UmZEMS82WzcPZUsOFYDsqesMo130_provenance.
- NP925526.RAFkIlJZ4V5Q5K_3mOw7UmZEMS82WzcPZUsOFYDsqesMo130_assertion wasGeneratedBy ECO_0000203 NP925526.RAFkIlJZ4V5Q5K_3mOw7UmZEMS82WzcPZUsOFYDsqesMo130_provenance.